Kenilworth, N.J. - Clarinex, a new systemic drug for treatmentof urticaria (hives), has been approved by the Food and Drug Administration(FDA), according to Schering-Plough, the drug's manufacturer.
POLL: Are You Attending Maui Derm NP+PA Fall 2023?
The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis
Phase 3 Trial Data Highlights Efficacy of OnabotulinutoxinA in Platysma Prominence
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
Abeona Submits Biologics License Application to FDA for EB-101
Botulinum Toxin Lacks Significant Effect in Seborrheic Dermatitis, Study Says
2 Clarke Drive Cranbury, NJ 08512